179 related articles for article (PubMed ID: 34122724)
21. Melatonin Ameliorates Renal Fibrosis Through the Inhibition of NF-κB and TGF-β1/Smad3 Pathways in db/db Diabetic Mice.
Fan Z; Qi X; Yang W; Xia L; Wu Y
Arch Med Res; 2020 Aug; 51(6):524-534. PubMed ID: 32473749
[TBL] [Abstract][Full Text] [Related]
22. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
23. C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway.
You YK; Huang XR; Chen HY; Lyu XF; Liu HF; Lan HY
Sci Rep; 2016 May; 6():26740. PubMed ID: 27221338
[TBL] [Abstract][Full Text] [Related]
24. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-29b inhibits diabetic nephropathy in db/db mice.
Chen HY; Zhong X; Huang XR; Meng XM; You Y; Chung AC; Lan HY
Mol Ther; 2014 Apr; 22(4):842-53. PubMed ID: 24445937
[TBL] [Abstract][Full Text] [Related]
26. Smad3 deficiency improves islet-based therapy for diabetes and diabetic kidney injury by promoting β cell proliferation
Wang HL; Wei B; He HJ; Huang XR; Sheng JY; Chen XC; Wang L; Tan RZ; Li JC; Liu J; Yang SJ; Ma RC; Lan HY
Theranostics; 2022; 12(1):379-395. PubMed ID: 34987651
[No Abstract] [Full Text] [Related]
27. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo.
Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G
Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117
[TBL] [Abstract][Full Text] [Related]
30. Novel Interplay Between Smad1 and Smad3 Phosphorylation via AGE Regulates the Progression of Diabetic Nephropathy.
Ono H; Abe H; Sakurai A; Ochi A; Tominaga T; Tamaki M; Kishi S; Murakami T; Nagai K; Kohashi M; Doi T
Sci Rep; 2018 Jul; 8(1):10548. PubMed ID: 30002389
[TBL] [Abstract][Full Text] [Related]
31. A protective role of renalase in diabetic nephropathy.
Yin J; Liu X; Zhao T; Liang R; Wu R; Zhang F; Kong Y; Liu L; Xing T; Wang N; Zhao Q; Wang F
Clin Sci (Lond); 2020 Jan; 134(1):75-85. PubMed ID: 31899483
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1/FOXO3a pathway.
Wang X; Meng L; Zhao L; Wang Z; Liu H; Liu G; Guan G
Diabetes Res Clin Pract; 2017 Apr; 126():172-181. PubMed ID: 28258028
[TBL] [Abstract][Full Text] [Related]
33. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
34. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
35. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
36. Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.
Li L; Emmett N; Mann D; Zhao X
Exp Biol Med (Maywood); 2010 Mar; 235(3):383-91. PubMed ID: 20404057
[TBL] [Abstract][Full Text] [Related]
37. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis.
Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L
Int Immunopharmacol; 2024 May; 135():112303. PubMed ID: 38776855
[TBL] [Abstract][Full Text] [Related]
38. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.
Dong Z; Yang J; Li L; Tan L; Shi P; Zhang J; Zhong X; Ge L; Wu Z; Cui H
Int J Oncol; 2020 Mar; 56(3):728-742. PubMed ID: 32124950
[TBL] [Abstract][Full Text] [Related]
39. PI3K/AKT activation attenuates acute kidney injury following liver transplantation by inducing FoxO3a nuclear export and deacetylation.
Meng F; Zhang Z; Chen C; Liu Y; Yuan D; Hei Z; Luo G
Life Sci; 2021 May; 272():119119. PubMed ID: 33508296
[TBL] [Abstract][Full Text] [Related]
40. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease.
Kato M; Yuan H; Xu ZG; Lanting L; Li SL; Wang M; Hu MC; Reddy MA; Natarajan R
J Am Soc Nephrol; 2006 Dec; 17(12):3325-35. PubMed ID: 17082237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
